~~<i id='A1F0785631'><strike id='A1F0785631'><tt id='A1F0785631'><pre id='A1F0785631'></pre></tt></strike></i>~~

Home» explore» entertainment

entertainment

author：knowledge 2025-09-29 20:41:38 Page View：47912

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

focus

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

BoxesofmifepristoneAllenG.Breed/APThedrugstorechainsCVSHealthandWalgreensplantostartdispensingan abo

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Obesity now affects over 1 billion people worldwide, study finds

AdobeMorethan1billionpeople—oroneineightpeopleworldwide—arenowestimatedtohaveobesity,anewstudyfinds.